View this email on AZBio.org |
Arizona Senate honors our Arizona Bioscience Community
You can read the Proclamation and watch the video here.
|
AZBio Member News
|
|
Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment decisions, today announced that it has received its Clinical Laboratory Permit from the New York State Department of Health, including approval for three clinical tests. The receipt of the New York permit allows patients in that state to benefit from the Company’s DecisionDx®-Melanoma, DecisionDx®-UM and DecisionDx®-PRAME molecular diagnostic tests that provide actionable molecular information to inform patient care decisions.
The National Medal of Technology and Innovation (NMTI) is now accepting nominations for 2018. Awarded by the President of the United States, the NMTI is the nation’s highest honor for technological achievement. If you know of an individual, team, or company that has made an outstanding technological contribution to United States’ economic, environmental, or social well-being, you can submit nominations until the April 6 deadline. The nomination form, a sample recommendation letter, and FAQs are available on the NMTI website.
Destroy Pancreatic Cancer, an Atlanta-based non-profit dedicated to finding better treatments for the most deadly of all cancers, is donating $1 million for a unique pancreatic cancer clinical trial designed by the non-profit Translational Genomics Research Institute (TGen). |
Opportunity Alerts
|
Looking for Investors? Applications are open for White Hat 2018
First Round Judging begins in May. All applicants will know their status by August 1st.
|
Grow Faster By Going Global: Connect With Chinese Investors And Strategic Partners. Apply now to join AZBio’s CEO at InnoSTARS in Houston May 14-15, 2018 |
Tell us who inspires you…
 Nominations are open for the 2018 AZBio Awards. Learn More
Applications are now open for the Student Discovery Zone. Learn More
|
Post your open career opportunities today at Jobs.AZBio.org
Check out career opportunities with Critical Path Institute, Regenesis Biomedical, and Pinnacle Transplant Technologies.
|
Do YOU have news to share with our community?
Send your news and events to JKW@AZBio.org.
(For better formatting, please do not send PDF’s.)
|
|
Events – Committees – Savings
|
To learn more about AZBio click here
Thank you to our AZBio Supporters
|
Legacy Level: Arizona Commerce Authority * BIO * Dorn Policy Group * Flinn Foundation |
Chairman’s Circle: Bard Peripheral Vascular * BusinessWire
City of Phoenix * City of Tempe * Johnson & Johnson * Roche
|
| Leadership Level: Alliant Insurance * Amanda Vega Consulting * Amgen * Arizona Science Center * City of Scottsdale * Cord Blood Registry (CBR) * Dignity Health * Genentech * Janssen Biotech * KCA * Medtronic Tempe Campus * New Angle Media * Northern Arizona University * Novartis * Pfizer * PhRMA * Roche Diagnostics * TGen * The Biodesign Institute at ASU * UA BIO5 * Ulthera * University of Arizona * Ventana Medical Systems * VWR |
Sustaining Partners: AdvaMed * Affordable Image * Alliance Bank of Arizona * Allergan * APS * Bank of America * Bristol-Myers Squibb * EY * International Research Center * Merrill Lynch * Midwestern University * NFP * PADT Medical * Pinnacle Transplant Technologies * Snell & Wilmer * U.S. Trust
|
AZBio Supporters make what we do possible.
Download the 2018 AZBio Prospectus to learn more.
|
Copyright © 2018 AZBio. All rights reserved.
Arizona BioIndustry Association, Inc.
|
|
|
|
